D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 82 Citations 23,891 194 World Ranking 276 National Ranking 144
Medicine D-index 106 Citations 35,912 367 World Ranking 2924 National Ranking 1694

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Tuberculosis

His main research concerns Internal medicine, Immunology, Acquired immunodeficiency syndrome, Tuberculosis and Viral disease. His Internal medicine research incorporates themes from Pyrazinamide, Surgery and Ethambutol. His study in Immunology is interdisciplinary in nature, drawing from both Disease, Retrospective cohort study and Risk factor.

His Acquired immunodeficiency syndrome research is multidisciplinary, incorporating perspectives in Health care, Pharmacotherapy, Viral load and Cohort study. His Tuberculosis research includes themes of Moxifloxacin and Chemoprophylaxis. His Viral disease research integrates issues from Immunopathology and Pneumonia.

His most cited work include:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. (491 citations)
  • USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus (404 citations)

What are the main themes of his work throughout his whole career to date?

Richard E. Chaisson spends much of his time researching Tuberculosis, Internal medicine, Immunology, Acquired immunodeficiency syndrome and Surgery. His work carried out in the field of Tuberculosis brings together such families of science as Incidence, Pediatrics and Disease. His research in Internal medicine focuses on subjects like Pyrazinamide, which are connected to Ethambutol.

As part of the same scientific family, Richard E. Chaisson usually focuses on Immunology, concentrating on Regimen and intersecting with Intensive care medicine. His study looks at the intersection of Acquired immunodeficiency syndrome and topics like Viral disease with Immunopathology. The study incorporates disciplines such as Rifapentine, Latent tuberculosis and Chemoprophylaxis in addition to Isoniazid.

He most often published in these fields:

  • Tuberculosis (53.33%)
  • Internal medicine (48.05%)
  • Immunology (35.86%)

What were the highlights of his more recent work (between 2014-2021)?

  • Tuberculosis (53.33%)
  • Internal medicine (48.05%)
  • Rifapentine (5.06%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Tuberculosis, Internal medicine, Rifapentine, Isoniazid and Regimen. The Tuberculosis study combines topics in areas such as Clinical trial, Randomized controlled trial, Intensive care medicine, Disease and Pediatrics. His Internal medicine research focuses on Adverse effect in particular.

His work in Isoniazid covers topics such as Pharmacokinetics which are related to areas like Interquartile range and Efavirenz. Viral load is a subfield of Immunology that Richard E. Chaisson investigates. Many of his studies involve connections with topics such as Logistic regression and Immunology.

Between 2014 and 2021, his most popular works were:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. (491 citations)
  • Building a tuberculosis-free world: The Lancet Commission on tuberculosis (118 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

The scientist’s investigation covers issues in Tuberculosis, Internal medicine, Immunology, Disease and Mycobacterium tuberculosis. The various areas that Richard E. Chaisson examines in his Tuberculosis study include Regimen, Cause of death, Obstetrics, Coinfection and Pharmacology. He studies Internal medicine, namely Randomized controlled trial.

Richard E. Chaisson combines subjects such as Acute Retroviral Syndrome, Antiretroviral therapy and Scabies with his study of Immunology. His research integrates issues of Tuberculosis diagnosis and Environmental health in his study of Disease. The concepts of his Mycobacterium tuberculosis study are interwoven with issues in Increased risk, Acquired immunodeficiency syndrome, Transmission, Global health and Airborne disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)

3959 Citations

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Payam Nahid;Susan E. Dorman;Narges Alipanah;Pennan M. Barry.
Clinical Infectious Diseases (2016)

740 Citations

Natural history of HIV infection in the era of combination antiretroviral therapy.

Richard D. Moore;Richard E. Chaisson.
AIDS (1999)

614 Citations

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

David Lanier;Neil Schram;Ellen Cooper;Kenneth A. Freedberg.
Clinical Infectious Diseases (1995)

606 Citations

Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS

Stephen D. Nightingale;D. William Cameron;Fred M. Gordin;Paul M. Sullam.
The New England Journal of Medicine (1993)

497 Citations

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes

Jean B. Nachega;Michael Hislop;David W. Dowdy;Richard E. Chaisson.
Annals of Internal Medicine (2007)

443 Citations

Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban Community

Richard D. Moore;David Stanton;Ramana Gopalan;Richard E. Chaisson.
The New England Journal of Medicine (1994)

435 Citations

Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.

Jean B Nachega;Michael Hislop;Hoang Nguyen;David W Dowdy.
Journal of Acquired Immune Deficiency Syndromes (2009)

432 Citations

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

Jonathan E Golub;Valeria Saraceni;Solange C Cavalcante;Antonio G Pacheco.
AIDS (2007)

407 Citations

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

Eric L. Nuermberger;Tetsuyuki Yoshimatsu;Sandeep Tyagi;Richard J. O'Brien.
American Journal of Respiratory and Critical Care Medicine (2004)

401 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Richard E. Chaisson

Stephen D. Lawn

Stephen D. Lawn

University of London

Publications: 129

Gavin J. Churchyard

Gavin J. Churchyard

Aurum Institute

Publications: 115

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 108

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 106

Robin Wood

Robin Wood

University of Cape Town

Publications: 99

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 89

Eric L. Nuermberger

Eric L. Nuermberger

Johns Hopkins University

Publications: 87

Robert J. Wilkinson

Robert J. Wilkinson

The Francis Crick Institute

Publications: 86

Anthony D. Harries

Anthony D. Harries

International Union Against Tuberculosis and Lung Disease

Publications: 82

Dick Menzies

Dick Menzies

McGill University

Publications: 78

Jean B. Nachega

Jean B. Nachega

University of Pittsburgh

Publications: 77

Keertan Dheda

Keertan Dheda

University of Cape Town

Publications: 75

Kenneth A. Freedberg

Kenneth A. Freedberg

Harvard University

Publications: 73

Timothy R. Sterling

Timothy R. Sterling

Vanderbilt University

Publications: 71

David R. Bangsberg

David R. Bangsberg

Oregon Health & Science University

Publications: 68

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 66

Something went wrong. Please try again later.